These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3085598)

  • 41. Comparative expression of bullous pemphigoid antigens in normal human epidermis and cultured keratinocytes.
    Su H; Reano A; Viac J; Thivolet J
    Clin Immunol Immunopathol; 1989 Jun; 51(3):406-13. PubMed ID: 2656012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
    Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
    J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
    [No Abstract]   [Full Text] [Related]  

  • 43. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
    Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
    J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
    Hara H; Makino T; Matsui K; Takegami Y; Koga H; Fukuda S; Ishii N; Hashimoto T; Shimizu T
    Eur J Dermatol; 2014; 24(4):488-9. PubMed ID: 25178966
    [No Abstract]   [Full Text] [Related]  

  • 45. Modulation of bullous pemphigoid antigens by gamma interferon in cultured human keratinocytes.
    Su H; Reano A; Hesse S; Viac J; Thivolet J
    J Dermatol; 1990 Jan; 17(1):16-23. PubMed ID: 2109762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
    Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
    Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
    [No Abstract]   [Full Text] [Related]  

  • 47. The hemidesmosome: a target in auto-immune bullous disease.
    Eady RA
    Dermatology; 1994; 189 Suppl 1():38-41. PubMed ID: 8049561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens.
    Robledo MA; Kim SC; Korman NJ; Stanley JR; Labib RS; Futamura S; Anhalt GJ
    J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and immunological factors associated with bullous pemphigoid relapse.
    Fine JD
    JAMA Dermatol; 2014 Jan; 150(1):34. PubMed ID: 24226151
    [No Abstract]   [Full Text] [Related]  

  • 50. Localized pretibial pemphigoid and pemphigoid nodularis.
    Borradori L; Prost C; Wolkenstein P; Bernard P; Baccard M; Morel P
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 2):863-7. PubMed ID: 1469147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bullous colon lesions in a patient with bullous pemphigoid.
    Sachsenberg-Studer EM; Runne U; Wehrmann T; Wolter M; Kriener S; Engels K; Elshorst-Schmidt T; Kaufmann R; Borradori L
    Gastrointest Endosc; 2001 Jul; 54(1):104-8. PubMed ID: 11427857
    [No Abstract]   [Full Text] [Related]  

  • 52. Association of KM genotype with bullous pemphigoid.
    Raux G; Gilbert D; Joly P; Daveau M; Martel P; Christ M; Tron F
    J Autoimmun; 2000 Feb; 14(1):79-82. PubMed ID: 10648118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.
    Stanley JR; Tanaka T; Mueller S; Klaus-Kovtun V; Roop D
    J Clin Invest; 1988 Dec; 82(6):1864-70. PubMed ID: 2461961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 230-kD basic protein is the major bullous pemphigoid antigen.
    Mueller S; Klaus-Kovtun V; Stanley JR
    J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new bullous pemphigoid antigen.
    Fujiwara S; Kohno K; Iwamatsu A; Shinkai H
    Dermatology; 1994; 189 Suppl 1():120-2. PubMed ID: 8049550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: the anti-230-kDa autoantibody is not synthesized by leukaemic cells.
    Misery L; Cambazard F; Rimokh R; Ghohestani R; Magaud JP; Gaudillere A; Perrot JL; Berard F; Claudy A; Guyotat D; Schmitt D; Vincent C
    Br J Dermatol; 1999 Jul; 141(1):155-7. PubMed ID: 10417535
    [No Abstract]   [Full Text] [Related]  

  • 57. Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid.
    Konishi N; Suzuki K; Tokura Y; Hashimoto T; Takigawa M
    Acta Derm Venereol; 2000; 80(4):281-3. PubMed ID: 11028862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bullous pemphigoid associated with Shy-Drager syndrome.
    Okazaki A; Iida T; Muramatsu T; Shirai T; Murata K; Takayanagi T
    J Dermatol; 1998 Jul; 25(7):465-8. PubMed ID: 9714981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 230-kD and 180-kD bullous pemphigoid antigens are distinct gene products.
    Sawamura D; Li K; Uitto J
    J Invest Dermatol; 1992 Jun; 98(6):942-3. PubMed ID: 1497743
    [No Abstract]   [Full Text] [Related]  

  • 60. Lichenoid erythrodermic bullous pemphigoid of the African patient.
    Joly P; Tanasescu S; Wolkenstein P; Bocquet H; Gilbert D; Thomine E; Wechsler J; Roujeau JC; Revuz J; Tron F; Lauret P
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):691-7. PubMed ID: 9810884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.